Диссертация (1139920), страница 17
Текст из файла (страница 17)
Cell Biochem. – 2009. – Vol.330(1–2). –P. 63–70.209. Voors A.A., Ruschitzka F. The year in cardiology: heart failure 2014// Eur. Heart J. - 2015. – Vol.36. – P. 421–424.210. Wan F. S., Li G. H., Zhang J. et al. Protective effects of taurine onmyocardial mitochondria and their enzyme activities in rate with severe burn //Zhonghua Shao Shang Za Zhi. - 2008. - Vol. 24. - P. 171-174.211. Wang G.G., Li W., Lu X.H. et al. Taurine attenuates oxidative stress116and alleviates cardiac failure in type I diabetic rats // Croat.
Med. J. – 2013. –Vol.54 (2). – P.171-179.212. Wang Q., Fan W., Cai Y. et al. Protective effects of taurine intraumatic brain injury via mitochondria and cerebral blood flow // Amino Acids. –2016. – Vol.48 (9). - P.2169-2177.213. Wójcik O.P., Koenig K.L., Zeleniuch-Jacquotte A. et al. The potentialprotective effects of taurine on coronary heart disease // Atherosclerosis. - 2010. Vol. 208.- P.19-25.214. Woo S.K., Lee S.D., Kwon HM. TonEBP transcriptional activator inthe cellular response to increased osmolality // Pflugers Archiv.
Eur. J. Physiol. 2002. – Vol. 444. – P. 579–585.215. Wu H., JIN Y., Wei J., et al. Mode of action of taurine as aneuroprotector // Brain Res. - 2005. - Vol. 1038. - P.123–131.216. Wu J., Kohno T., Georgiev S. et al. Taurine activates glycine and[gamma]-aminobutyric and A receptors in rat substancia gelatinosa neurons //Neuroreport.- 2008.- Vol.19, № 3.- Р 333-337.217. Xiao B., Liu H., Gu Z. et al. Taurine Protected Against theImpairments of Neural Stem Cell Differentiated Neurons Induced by OxygenGlucose Deprivation // Neurochem. Res. - 2015.
– Vol.40 (11). – P.2348-2356.218. Xu Y. J., Arneja A. S., Tappia P S., Dhalla N. S. The potential healthbenefits of taurine in cardiovascular disease // Exp. Clin. Cardiol. - 2008. - Vol.13 (2). - P.57-65.219.Yamashita A., Singh S., Kawate T. et al. Crystal structure of abacterial homologue of Na+/Cl–dependent neurotransmitter transporters // Nature.- 2005. – Vol. 437. – P. 215–223.220. Yamori Y., Taguchi T., Hamada A. et al. Taurine in health anddiseases: consistent evidence from experimental and epidemiological studies // J.Biomed.
Sci. - 2010. – Vol.17, Suppl.1. – P.6.221. Yanagita T., Han S.Y., Hu Y. et al. Taurine reduces the secretion ofapolipoprotein B100 and lipids in HepG2 cells // Lipids in Health and Disease. -1172008. – Vol.7. – P.38.222. Yang Y.J., Han Y.Y., Chen K. et al. TonEBP modulates the protectiveeffect of taurine in ischemia-induced cytotoxicity in cardiomyocytes // Cell DeathDis. – 2015.
- Dec 17;6:e2025.223. Yang Y., Yang L., Zhang Y. et al. Taurine detected using highresolution magic angle spinning (1)H nuclear magnetic resonance: a potentialindicator of early myocardial infarction // Exp. Ther. Med. - 2013. – Vol. 5. – P.683–688.224. Yang Y., Zhang Y., Liu X. et al. Exogenous taurine attenuatesmitochondrial oxidative stress and endoplasmic reticulum stress in ratcardiomyocytes // Acta Biochim.
Biophys. Sin. (Shanghai). - 2013. – Vol.45 (5). –P.359-367.225. Yoshioka M., Takasugi Y., Koga Y. Central hypotensive effectinvolving neurotransmitters of long-term administration of taurine to stroke-pronespontaneously hypertensive rat // Masui. – 2007. –Vol. 56(2). – P.139–147.226.Zhang Y., Yang L., Yang Y. et al. Low-dose taurine upregulatestaurine transporter expression in acute myocardial ischemia // Int. J.
Mol. Med. 2013. – Vol. 31. – P. 817–824.227. Zhao L., Lou J., Wu H. et al. Effects of Taurine-MagnesiumCoordination Compound on Ionic Channels in Rat Ventricular Myocytes ofArrhythmia Induced by Ouabain // Biol. Trace Elem. Res. – 2012. - Feb 5. (85)..
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
